Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Deusch

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface moleculesK Deusch, J F Daley, H Levine, et al.
Immunology Series|January 1, 1993
Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?G Riethmüller, K Deusch, M E Sanders, et al.
The Journal of Experimental Medicine|January 1, 1992
Oligoclonality of human intestinal intraepithelial T cellsC Van Kerckhove, G J Russell, K Deusch, et al.
Transplantation Proceedings|February 1, 1993
TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survivalC D Heidecke, W W Hancock, F Jakobs, et al.
Transplantation|January 15, 1995
alpha/beta-T cell receptor-directed therapy in rat cardiac allograft recipients. Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejectionC D Heidecke, W W Hancock, F Jakobs, et al.
Immunological Reviews|October 1, 1992
From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune diseaseG Riethmüller, E P Rieber, S Kiefersauer, et al.
Transplantation|March 27, 1996
alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokinesC D Heidecke, W W Hancock, S Westerholt, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface moleculesK Deusch, J F Daley, H Levine, et al.
Immunology Series|January 1, 1993
Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?G Riethmüller, K Deusch, M E Sanders, et al.
The Journal of Experimental Medicine|January 1, 1992
Oligoclonality of human intestinal intraepithelial T cellsC Van Kerckhove, G J Russell, K Deusch, et al.
Transplantation Proceedings|February 1, 1993
TCR alpha/beta targeted therapy in the rat: pretreatment with R73 monoclonal antibody induces profound immunological anergy and long-term allograft survivalC D Heidecke, W W Hancock, F Jakobs, et al.
Transplantation|January 15, 1995
alpha/beta-T cell receptor-directed therapy in rat cardiac allograft recipients. Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejectionC D Heidecke, W W Hancock, F Jakobs, et al.
Immunological Reviews|October 1, 1992
From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune diseaseG Riethmüller, E P Rieber, S Kiefersauer, et al.
Transplantation|March 27, 1996
alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokinesC D Heidecke, W W Hancock, S Westerholt, et al.
Pageof 3